Skip to main content
. 2016 Apr 2;13:17. doi: 10.1186/s12981-016-0101-3

Fig. 1.

Fig. 1

Kaplan-Meier survival probability without grade 2 or more ALT elevation according to the use of tipranavir (TPV) in baseline regimen (BR)